AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Qualigen shares surge 10.62% premarket after shareholder approval confirms Faraday Future's 55% stake and rebrand to AIxCrypto, signaling strategic shift to AI×Web3.
ByAinvest
Monday, Nov 17, 2025 4:21 am ET1min read
Qualigen Therapeutics surged 10.62% in premarket trading following shareholder approval of a strategic transformation. The company announced it will rebrand as AIxCrypto Holdings, Inc. (NASDAQ: AIXC) on November 20, 2025, after Faraday Future became its majority shareholder with 55% direct equity ownership (63% including affiliates). The rebranding includes governance restructuring, with Faraday Future nominating a majority of board seats, and a shift from biotechnology to a decentralized AI × Web3 technology platform. The news highlights a new three-year roadmap and ecosystem integration plans, positioning AIxCrypto as a gateway to the AI × Web3 era. The approval of share issuances and governance changes, coupled with the anticipated Nasdaq renaming ceremony, signaled a definitive pivot toward high-growth tech sectors, driving investor optimism.
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet